OncLive’s December Roundup of Key FDA Approvals in Oncology
Below is your guide to all treatment options that the FDA cleared in December 2024. The recap spotlights the topline data that supported the regulatory decisions and features expert insights on what they mean for clinical practice. 12/4: Durvalumab in …